Chugai Pharmaceutical Co. Ltd. (CHGCY)
OTC
22.19
+0.10 (+0.45%)
Closed
Aug 21, 2026
Day's Range
21.9322.96
52 wk Range
20.2734.84
Financial Statements - CHGCY - Chugai Pharmaceutical Co. Ltd.
Revenue
1.25T▲ 7.5%
Net Income
434.01B▲ 12.1%Net Margin 34.5%
EBITDA
598.01B▲ 10.3%
Free Cash Flow
274.67B▼ 30.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.25T | 1.17T | 7.52B | 1.25T | 999.75B | 786.94B |
| Cost of Goods | 363.69B | 339.40B | 2.79B | 476.25B | 338.14B | 273.46B |
| Gross Profit | 894.25B | 831.20B | 4.72B | 783.47B | 661.61B | 513.48B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 598.83B | 542B | 2.97B | 533.30B | 421.89B | 301.23B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 597.80B | 543.03B | 3B | 531.16B | 419.38B | 298.18B |
| Income Tax | 163.79B | 155.71B | 801.57M | 156.73B | 116.39B | 83.45B |
| Net Income | 434.01B | 387.31B | 2.20B | 374.42B | 302.99B | 214.73B |
| EPS Basic | 131.865 | 117.695 | 98.915 | 113.82 | 92.145 | 65.33 |
| EPS Diluted | 131.86 | 117.68 | 98.9 | 113.785 | 92.085 | 65.265 |
| Basic Shares Outstanding | 3.29B | 3.29B | 22.28M | 508.92B | 508.59B | 508.38B |
| Diluted Shares Outstanding | 3.29B | 3.29B | 22.28M | 508.92B | 508.59B | 508.38B |
| Ebit | 598.01B | 542B | 3B | 531.22B | 419.43B | 298.25B |
| Ebitda | 598.01B | 542B | 3B | 531.22B | 419.43B | 298.25B |
| Net Income Continuous Operations | 650.93B | 589.54B | 3.13B | 575.34B | 470.36B | 340.22B |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
